Filing Details

Accession Number:
0001140361-15-019190
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-12 18:48:28
Reporting Period:
2015-05-08
Filing Date:
2015-05-12
Accepted Time:
2015-05-12 18:48:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1293818 Opgen Inc OPGN,OPGNW Services-Medical Laboratories (8071) 061614015
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1641611 Jven Capital, Llc 11009 Cripplegate Road
Potomac MD 20854
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-08 445,000 $6.00 445,000 No 4 P Direct
Common Stock Acquisiton 2015-05-08 1,059,213 $0.00 1,504,213 No 4 C Direct
Common Stock Acquisiton 2015-05-08 749,366 $0.00 2,253,579 No 4 C Direct
Common Stock Acquisiton 2015-05-08 675,553 $0.00 2,929,132 No 4 C Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
No 4 C Direct
No 4 C Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Redeemable Convertible Preferred Stock Disposition 2015-05-08 1,059,213 $0.00 1,059,213 $0.00
Common Stock 2014 Convertible Notes Disposition 2015-05-08 749,366 $0.00 749,366 $0.00
Common Stock 2015 Convertible Notes Disposition 2015-05-08 675,553 $0.00 675,553 $0.00
Common Stock Warrants Acquisiton 2015-05-08 445,000 $0.00 445,000 $6.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 C Direct
445,000 2015-05-08 2020-05-08 No 4 P Direct
Footnotes
  1. Series A Redeemable Convertible Preferred Stock automatically converted into common stock on a 1-to-1 basis upon the consummation of the Company's initial public offering.
  2. The 2014 Convertible Notes automatically converted into shares of Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of one share of Series A Preferred Stock for every $1.00 of principal converted. Each share of Series A Preferred Stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.
  3. The 2015 Convertible Notes converted into Series A Preferred Stock upon the consummation of the Company's initial public offering at a conversion rate of 1.25 shares of Series A Preferred Stock for each $1.00 of principal converted. Each share of Series A Preferred stock automatically converted into one share of common stock upon the consummation of the Company's initial public offering.